Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.10.5241

Association Between Single Nucleotide Polymorphisms in the XRCC1 Gene and Susceptibility to Prostate Cancer in Chinese Men  

Zhou, Yun-Feng (Department of Urology, The First Affiliated Hospital of Soochow University)
Zhang, Guang-Bo (Department of Urology, The First Affiliated Hospital of Soochow University)
Qu, Ping (Department of Urology, The First People's Hospital of Yancheng)
Zhou, Jian (Department of Urology, The First People's Hospital of Yancheng)
Pan, Hui-Xin (Department of Urology, The First Affiliated Hospital of Soochow University)
Hou, Jian-Quan (Department of Urology, The First Affiliated Hospital of Soochow University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.10, 2012 , pp. 5241-5243 More about this Journal
Abstract
Background: Prostate cancer (Pca) is one of the most common complex and polygenic diseases in men. The X-ray repair complementing group 1 gene (XRCC1) is an important candidate in the pathogenesis of Pca. The purpose of this study was to evaluate the association between single nucleotide polymorphisms in the XRCC1 gene and susceptibility to Pca. Materials and Methods: XRCC1 gene polymorphisms and associations with susceptibility to Pca were investigated in 193 prostate patients and 188 cancer-free Chinese men. Results: The c.910A>G variant in the exon9 of XRCC1 gene could be detected by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and DNA sequencing methods. Significantly increased susceptibility to prostate cancer was noted in the homozygote comparison (GG versus AA: OR=2.95, 95% CI 1.46-5.42, ${\chi}^2$=12.36, P=0.001), heterozygote comparison (AG versus AA: OR=1.76, 95% CI 1.12-2.51, ${\chi}^2$=4.04, P=0.045), dominant model (GG/AG versus AA: OR=1.93, 95% CI 1.19-2.97, ${\chi}^2$=9.12, P=0.003), recessive model (GG versus AG+AA: OR=2.17, 95% CI 1.33-4.06, ${\chi}^2$=8.86, P=0.003) and with allele contrast (G versus A: OR=1.89, 95% CI 1.56-2.42, ${\chi}^2$=14.67, P<0.000). Conclusions: These findings suggest that the c.910A>G polymorphism of the XRCC1 gene is associated with susceptibility to Pca in Chinese men, the G-allele conferring higher risk.
Keywords
Prostate cancer; XRCC1 gene; single nucleotide polymorphism; susceptibility; Chinese men;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Agalliu I, Kwon EM, Salinas CA, et al (2010). Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based stusdy. Cancer Causes Control, 21, 289-300.   DOI
2 Berhane N, Sobti RC, Mahdi SA (2012). DNA repair genes polymorphism (XPG and XRCC1) and association of prostate cancer in a north Indian population. Mol Biol Rep, 39, 2471-9.   DOI   ScienceOn
3 Dhillon VS, Yeoh E, Fenech M (2011). DNA repair gene polymorphisms and prostate cancer risk in South Australia--results of a pilot study. Urol Oncol, 29, 641-6.   DOI   ScienceOn
4 Geng J, Zhang Q, Zhu C, et al (2009). XRCC1 genetic polymorphism Arg399Gln and prostate cancer risk: a meta-analysis. Urology, 74, 648-53.   DOI   ScienceOn
5 Hirata H, Hinoda Y, Tanaka Y, et al (2007). Polymorphisms of DNA repair genes are risk factors for prostate cancer. Eur J Cancer, 43, 231-7.   DOI
6 Jemal A, Siegel R, Ward E, et al (2008). Cancer statistics, 2008. CA Cancer J Clin, 58, 71-96.   DOI   ScienceOn
7 Kuasne H, Rodrigues IS, Losi-Guembarovski R, et al (2011). Base excision repair genes XRCC1 and APEX1 and the risk for prostate cancer. Mol Biol Rep, 38, 1585-91.   DOI
8 Langsenlehner T, Renner W, Gerger A, et al (2011). Association between single nucleotide polymorphisms in the gene for XRCC1 and radiation-induced late toxicity in prostate cancer patients. Radiother Oncol, 98, 387-93.   DOI
9 Lichtenstein P, Holm NV, Verkasalo PK, et al (2000). Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med, 343, 78-85.   DOI
10 Mandal RK, Gangwar R, Mandhani A, et al (2010). DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India. DNA Cell Biol, 29, 183-90.   DOI
11 Mittal RD, Mandal RK, Gangwar R (2012). Base excision repair pathway genes polymorphism in prostate and bladder cancer risk in North Indian population. Mech Ageing Dev, 133, 127-32.   DOI   ScienceOn
12 Pienta KJ, Esper PS (1993). Risk factors for prostate cancer. Ann Intern Med, 118, 793-803.   DOI   ScienceOn
13 Schaid DJ (2004). The complex genetic epidemiology of prostate cancer. Hum Mol Genet, 13, R103-21.   DOI
14 Wei B, Xu Z, Ruan J, et al (2011). Re: Geng et al.: XRCC1 genetic polymorphism Arg399Gln and prostate cancer risk: a metaanalysis (Urology 2009;74:648-653). Urology, 78, 481-2.
15 Wei B, Zhou Y, Xu Z, et al (2011). XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: a metaanalysis. Prostate Cancer Prostatic Dis, 14, 225-31.   DOI